Surmodics StabilBlock

Register to receive a free US Market for In-Vitro Diagnostics Report Suite – 2016 report synopsis and brochure

Surmodics Launch StabilBlock® Immunoassay Stabilizer
Surmodics has announced the launch and immediate availability of StabilBlock®. StabilBlock Immunoassay Stabilizer reagent is used to reduce non-specific binding to boost immunoassay signal-to-noise ratios.

“As part of our commitment to being the premier provider of IVD assay components to improve performance and manufacturability of immunoassays, we continue to advance our offerings to meet the needs of our customers,” said Joe Stich, vice president and general manager of Surmodics IVD, the company’s In Vitro Diagnostics business. “We recognize that each assay has its own blocking requirements and our expanded portfolio of Immunoassay Stabilizers will enable assay developers to achieve the best results for each application.”

Surmodics offers a family of immunoassay stabilizers, which preserve the conformation and activity of dried proteins on a wide range of surfaces, keeping antibodies and antigens at peak performance for long durations. At the same time, the blocking mechanisms in these reagents reduce non-specific binding of interfering proteins to maximize assay sensitivity. With StabilBlock, StabilCoat® and StabilGuard® Immunoassay Stabilizers, the company now offers three options to assay developers with a combination of blocking efficacy and long-term dried stability that is unmatched in the industry.

Sekisui Diagnostics Expands Point of Care Product Offering with the FastPack® IP System
Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics product line through a recent partnership agreement with Qualigen, Inc. Sekisui Diagnostics is now the exclusive worldwide distributor of the FastPack IP System, Qualigen’s innovative point-of-care system.
Sekisui Diagnostics FastPack

“Our agreement with Qualigen expands our offering in the rapidly growing field of point-of-care diagnostics,” says Robert Schruender, President and COO of Sekisui Diagnostics. “FastPack IP is highly compatible with our current POC business, and our distributor relationships.”

In addition to immunoassay tests performed on the FastPack IP System, Sekisui Diagnostics provides a range of OSOM® rapid tests for Trichomonas and Bacterial Vaginosis to aid in diagnosis of vaginal infections; as well as tests for pregnancy, ulcer-causing Helicobacter pylori, mononucleosis, influenza, and streptococcus A, which is a market leading product.

“Practice efficiency may be enhanced by performing these tests onsite, providing an effective way for physicians to offer their patients the convenience of receiving test results and implementation of therapy in a single visit,” Schruender adds.

These point-of-care tests complement the company’s range of products, which also includes clinical chemistry reagents and systems; coagulation systems and reagents; and enzymes and specialty biochemicals for manufacturers.

For Further Information
More on the in vitro market in the U.S. can be found in the report series published by iData entitled US Market for In-Vitro Diagnostics Report Suite – 2016. This report covers the U.S. market segments for the Immunochemistry Market, Molecular Diagnostics Market, Molecular Blood Donor Screening Market, Hemostasis Market, Hematology Market, and Point of Care Diagnostic Device Market.

Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a US Market for In-Vitro Diagnostics Report Suite – 2016 report brochure and synopsis.

About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Large & Small Joints, Orthopedics, Orthopedic Trauma, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Anesthesiology, Wound Management, Ophthalmics, Dental Operatory Equipment and more.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch